Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial

1 Jan 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hemoglobinopathies and Related Disorders
Share to Parvovirus B19 Infection Studies
Share to Prenatal Screening and Diagnostics

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35075288
DOI: 10.1038/s41591-021-01650-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trialPMID 35075288Read ↗

Gene Therapy for Beta-Hemoglobinopathies: Milestones, New Therapies and ChallengesSemantic proximity Read ↗

Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trialSemantic proximity Read ↗

The potential of gene therapy approaches for the treatment of hemoglobinopathies: achievements and challengesSemantic proximity Read ↗

Gene Therapy for β-Hemoglobinopathies: From Discovery to Clinical TrialsSemantic proximity Read ↗

Gene Therapy for Hemoglobinopathies: Tremendous Successes and Remaining CaveatsSemantic proximity Read ↗

Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β A(T87Q) - Globin GeneSemantic proximity Read ↗

Lentiglobin Gene Therapy for Transfusion-Dependent β-Thalassemia: Update from the Northstar Hgb-204 Phase 1/2 Clinical StudySemantic proximity Read ↗

Gene Therapy for HemoglobinopathiesSemantic proximity Read ↗

Gene Therapy for HemoglobinopathiesSemantic proximity Read ↗

Gene Therapy for β-Hemoglobinopathies.Semantic proximity Read ↗

Gene Therapy Approaches to HemoglobinopathiesSemantic proximity Read ↗

Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB ‐206 studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.